Stockreport

How The Investment Story Is Shifting For Halozyme Therapeutics (HALO) After Recent Analyst Calls [Yahoo! Finance]

Halozyme Therapeutics, Inc.  (HALO) 
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: halozyme.com/investors/default.aspx
PDF Analysts have shifted their price targets for Halozyme Therapeutics into a US$75 to US$90 range, even as the model fair value estimate holds steady at US$84.5. The high [Read more]